{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:57:40Z","timestamp":1787497060893,"version":"build-2736575974"},"reference-count":120,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jaip.2023.01.008","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T02:26:13Z","timestamp":1674181573000},"page":"704-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Toward a Predict and Prevent Approach in Obstructive Airway Diseases"],"prefix":"10.1016","volume":"11","author":[{"given":"Simon","family":"Couillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayia","family":"Petousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate S.","family":"Smigiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor A.","family":"Molfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.01.008_bib1","series-title":"The Global Impact of Respiratory Disease","year":"2017"},{"key":"10.1016\/j.jaip.2023.01.008_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/thoraxjnl-2013-204114","article-title":"The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry","volume":"70","author":"O'Neill","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2023.01.008_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1053\/rmed.2002.1334","article-title":"The costs of exacerbations in chronic obstructive pulmonary disease (COPD)","volume":"96","author":"Andersson","year":"2002","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/thoraxjnl-2015-206800","article-title":"Asthma deaths: What now?","volume":"70","author":"Levy","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2023.01.008_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.01.008_bib6","series-title":"Global strategy for diagnosis, management and prevention of COPD","year":"2022"},{"key":"10.1016\/j.jaip.2023.01.008_bib7","series-title":"Global strategy for asthma management and prevention","year":"2022"},{"key":"10.1016\/j.jaip.2023.01.008_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib9","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1183\/20734735.0362-2018","article-title":"Over- and under-diagnosis in asthma","volume":"15","author":"Kavanagh","year":"2019","journal-title":"Breathe (Sheff)"},{"key":"10.1016\/j.jaip.2023.01.008_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1183\/09059180.00010410","article-title":"The role of small airways in obstructive airway diseases","volume":"20","author":"Burgel","year":"2011","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2023.01.008_bib11","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/rccm.200901-0047OC","article-title":"The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort","volume":"180","author":"Kohansal","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib13","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1378\/chest.10-1253","article-title":"COPD in never smokers: results from the population-based burden of obstructive lung disease study","volume":"139","author":"Lamprecht","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2023.01.008_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1411532","article-title":"Lung-function trajectories leading to chronic obstructive pulmonary disease","volume":"373","author":"Lange","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/COPD.S27480","article-title":"Lung function decline in COPD","volume":"7","author":"Tantucci","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2023.01.008_bib16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1164\/rccm.201202-0223OC","article-title":"Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease","volume":"185","author":"Drummond","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib17","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1106955","article-title":"Small-airway obstruction and emphysema in chronic obstructive pulmonary disease","volume":"365","author":"McDonough","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1164\/rccm.201511-2219OC","article-title":"Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease","volume":"194","author":"Bhatt","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib19","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04656-2020","article-title":"The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories","volume":"58","author":"Marcon","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.01.008_bib20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S2213-2600(16)00098-9","article-title":"Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis","volume":"4","author":"Lange","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: Toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.01.008_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma\u2014present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib24","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1183\/09031936.00162414","article-title":"Eosinophilic inflammation in COPD: prevalence and clinical characteristics","volume":"44","author":"Singh","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.01.008_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/ACI.0000000000000028","article-title":"Adult asthma biomarkers","volume":"14","author":"Kim","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib26","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201903-0599LE","article-title":"Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide, and their combination in severe asthma: a post hoc analysis","volume":"200","author":"Shrimanker","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib27","first-page":"00570","article-title":"Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)","volume":"8","author":"Couillard","year":"2021","journal-title":"ERJ Open Res"},{"issue":"Suppl","key":"10.1016\/j.jaip.2023.01.008_bib28","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1067\/mai.2000.110151","article-title":"Epidemiologic evidence for asthma and rhinitis comorbidity","volume":"106","author":"Leynaert","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib29","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jaci.2006.12.669","article-title":"Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma","volume":"119","author":"Kusel","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib30","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03823-2020","article-title":"Blood eosinophil counts and the development of obstructive lung disease: the Kangbuk Samsung Health Study","volume":"58","author":"Park","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.01.008_bib31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jaip.2020.07.055","article-title":"Blood eosinophil count as a predictor of lung function decline in healthy individuals","volume":"9","author":"Lee","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.01.008_bib32","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02536-2017","article-title":"Associations between blood eosinophils and decline in lung function among adults with and without asthma","volume":"51","author":"Hancox","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.01.008_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100544","article-title":"Bronchodilator response and lung function decline: associations with exhaled nitric oxide with regard to sex and smoking status","volume":"14","author":"Nerpin","year":"2021","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2023.01.008_bib34","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A3418","article-title":"FeNO as a potential prognostic and predictive marker of lung function decline in patients with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUEST","author":"Pavord","year":"2022","journal-title":"B93 Breakthroughs in Pediatric And Adult Asthma Clinical Trials"},{"key":"10.1016\/j.jaip.2023.01.008_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thoraxjnl-2021-217325","article-title":"Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2023.01.008_bib36","first-page":"348","article-title":"Canadian Thoracic Society 2021 guideline update: diagnosis and management of asthma in preschoolers, children and adults","volume":"5","author":"Yang","year":"2021","journal-title":"Can J Respir Crit Care Sleep Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib37","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1164\/rccm.202003-0625ST","article-title":"Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society Clinical Practice Guideline","volume":"201","author":"Nici","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib38","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaip.2023.01.008_bib39","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jaip.2023.01.008_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.202201-0209PP","article-title":"Blood eosinophils and chronic obstructive pulmonary disease: a Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 review","volume":"206","author":"Singh","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib41","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/resp.14147","article-title":"Oral corticosteroids stewardship for asthma in adults and adolescents: a position paper from the Thoracic Society of Australia and New Zealand","volume":"26","author":"Blakey","year":"2021","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2023.01.008_bib42","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0151-2019","article-title":"Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety","volume":"29","author":"Price","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2023.01.008_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00183-2021","article-title":"Antibiotics for asthma attacks: masking uncertainty","volume":"58","author":"Ramakrishnan","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.01.008_bib44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1164\/rccm.201904-0903SO","article-title":"Systematic literature review of systemic corticosteroid use for asthma management","volume":"201","author":"Bleecker","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1S","key":"10.1016\/j.jaip.2023.01.008_bib45","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jaip.2021.10.011","article-title":"A\u00a0practical guide to implementing SMART in asthma management","volume":"10","author":"Reddel","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.01.008_bib46","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1164\/rccm.202001-0133OC","article-title":"A\u00a0phase 2a, double-blind, placebo-controlled randomized trial of inhaled TLR9 agonist AZD1419 in asthma","volume":"203","author":"Psallidas","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib47","doi-asserted-by":"crossref","first-page":"00333","DOI":"10.1183\/23120541.00333-2019","article-title":"Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design","volume":"6","author":"Harrison","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2023.01.008_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2213-2600(20)30397-0","article-title":"Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial","volume":"9","author":"Heaney","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib49","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(99)01813-9","article-title":"Non-eosinophilic corticosteroid unresponsive asthma","volume":"353","author":"Pavord","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.01.008_bib50","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(56)92241-3","article-title":"Controlled trial of effects of cortisone acetate in status asthmaticus: report to the Medical Research Council by the subcommittee on clinical trails in asthma","volume":"268","year":"1956","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.01.008_bib51","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/thx.2006.073429","article-title":"Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma","volume":"62","author":"Berry","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2023.01.008_bib52","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/thoraxjnl-2021-217994","article-title":"Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2023.01.008_bib53","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1164\/rccm.202104-1040LE","article-title":"Fractional exhaled nitric oxide nonsuppression identifies corticosteroid-resistant type-2 signaling in severe asthma","volume":"204","author":"Couillard","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib54","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM195110112451501","article-title":"Clinical studies on the activity of orally administered cortisone","volume":"245","author":"Thorn","year":"1951","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib55","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/resp.14294","article-title":"Sub-stratification of type-2 high airway disease for therapeutic decision-making: a \u2018bomb\u2019 (blood eosinophils) meets \u2018magnet\u2019 (FeNO) framework","volume":"27","author":"Couillard","year":"2022","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2023.01.008_bib56","series-title":"Encyclopedia of respiratory medicine","first-page":"411","article-title":"Biological therapies for asthma","author":"Couillard","year":"2021"},{"key":"10.1016\/j.jaip.2023.01.008_bib57","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jaip.2015.05.005","article-title":"Progression of irreversible airflow limitation in asthma: correlation with severe exacerbations","volume":"3","author":"Matsunaga","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.01.008_bib58","article-title":"Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study","author":"Soremekun","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2023.01.008_bib59","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03054-2021","article-title":"Low dose oral corticosteroids in asthma associates with increased morbidity and mortality","volume":"60","author":"Skov","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.01.008_bib60","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.chest.2021.07.008","article-title":"How I do it: workup of severe asthma","volume":"160","author":"Couillard","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2023.01.008_bib61","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01785-2017","article-title":"Predictors of accelerated decline in lung function in adult-onset asthma","volume":"51","author":"Coumou","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.01.008_bib62","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01105-2021","article-title":"A\u00a0new piece in the puzzle: the eosinophil and the development of COPD","volume":"58","author":"Petousi","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.01.008_bib63","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(20)30053-9","article-title":"Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial","volume":"8","author":"Pavord","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib64","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S2213-2600(21)00124-7","article-title":"Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis","volume":"9","author":"Busse","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib65","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00413-2021","article-title":"Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma","volume":"58","author":"Kraft","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.01.008_bib66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib67","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/resp.14213","article-title":"Fluticasone furoate: CAPTAIN of fluticasones in type-2 inflammatory asthma","volume":"27","author":"Couillard","year":"2022","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2023.01.008_bib68","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib69","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.2147\/COPD.S170743","article-title":"Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization","volume":"13","author":"B\u00e9langer","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2023.01.008_bib70","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.chest.2016.10.003","article-title":"Eosinophils in COPD exacerbations are associated with increased readmissions","volume":"151","author":"Couillard","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2023.01.008_bib71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1916046","article-title":"Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD","volume":"383","author":"Rabe","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib72","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S2213-2600(19)30190-0","article-title":"Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial","volume":"7","author":"Pascoe","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib73","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib74","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(17)30217-5","article-title":"Eosinophils in COPD: just another biomarker?","volume":"5","author":"Bafadhel","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib75","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S2213-2600(19)30397-2","article-title":"The acute COPD exacerbation prediction tool (ACCEPT): a modelling study","volume":"8","author":"Adibi","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib76","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12890-017-0409-3","article-title":"The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA","volume":"17","author":"Suruki","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib77","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1901963","article-title":"Controlled trial of budesonide-formoterol as needed for mild asthma","volume":"380","author":"Beasley","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib78","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.01.008_bib79","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2213-2600(14)70201-2","article-title":"Benralizumab, an anti-interleukin 5 receptor \u03b1 monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study","volume":"2","author":"Castro","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib80","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib81","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJMoa1704064","article-title":"Tezepelumab in adults with uncontrolled asthma","volume":"377","author":"Corren","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib82","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib83","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-2600(17)30344-2","article-title":"Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies","volume":"6","author":"FitzGerald","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib84","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058215","article-title":"Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling","volume":"12","author":"Couillard","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaip.2023.01.008_bib85","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jaci.2020.08.026","article-title":"The intersect of genetics, environment, and microbiota in asthma-perspectives and challenges","volume":"147","author":"Tang","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib86","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0300-2896(04)75566-0","article-title":"Lung function evolution and respiratory symptoms [in Spanish]","volume":"40","author":"Molfino","year":"2004","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.jaip.2023.01.008_bib87","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/02770908209104771","article-title":"Bronchial asthma in the medical literature of Greek antiquity","volume":"19","author":"Marketos","year":"1982","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2023.01.008_bib88","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1164\/rccm.200502-257OE","volume":"171","author":"Chu","year":"2005","journal-title":"Asthma. Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104782","article-title":"Biologics or immunotherapeutics for asthma?","volume":"158","author":"Tay","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jaip.2023.01.008_bib90","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/j.jaip.2021.04.033","article-title":"Management strategies to reduce exacerbations in non-T2 asthma","volume":"9","author":"Murphy","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.01.008_bib91","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/all.12445","article-title":"Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma","volume":"69","author":"Kupczyk","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.01.008_bib92","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199101313240502","article-title":"Respiratory arrest in near-fatal asthma","volume":"324","author":"Molfino","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib93","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/ACI.0000000000000810","article-title":"Predicting the course of asthma from childhood until early adulthood","volume":"22","author":"Koefoed","year":"2022","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib94","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJMra1102783","article-title":"A\u00a0patient with asthma seeks medical advice in 1828, 1928, and 2012","volume":"366","author":"von Mutius","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib95","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.anai.2022.02.005","article-title":"Should we apply a treatable traits approach to asthma care?","volume":"128","author":"Melhorn","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib96","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","article-title":"An expert consensus framework for asthma remission as a treatment goal","volume":"145","author":"Menzies-Gow","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib97","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.anai.2022.04.020","article-title":"T2-low: What do we know? Past, present, and future of biologic therapies in noneosinophilic asthma","volume":"129","author":"Niessen","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib98","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41577-022-00735-y","article-title":"Role of thymic stromal lymphopoietin in allergy and beyond","volume":"23","author":"Ebina-Shibuya","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib99","doi-asserted-by":"crossref","DOI":"10.4414\/SMW.2022.w30176","article-title":"New perspectives of biological therapy for severe asthma in adults and adolescents","volume":"152","author":"Chheang","year":"2022","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jaip.2023.01.008_bib100","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/JAA.S275039","article-title":"Targeting TSLP in asthma","volume":"15","author":"Parnes","year":"2022","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2023.01.008_bib101","first-page":"10","article-title":"Which therapy for non-type(T)2\/T2-low asthma","volume":"12","author":"Ricciardolo","year":"2021","journal-title":"J\u00a0Pers Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib102","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1814917","article-title":"Mometasone or tiotropium in mild asthma with a low sputum eosinophil level","volume":"380","author":"Lazarus","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib103","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1513\/AnnalsATS.202001-046ST","article-title":"Outdoor air pollution and new-onset airway disease. An official American Thoracic Society Workshop Report","volume":"17","author":"Thurston","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2023.01.008_bib104","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaci.2021.07.011","article-title":"The maternal gut microbiome during pregnancy and offspring allergy and asthma","volume":"148","author":"Gao","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib105","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.3390\/ijerph18147465","article-title":"Exposure to stress and air pollution from bushfires during pregnancy: could epigenetic changes explain effects on the offspring?","volume":"18","author":"Murphy","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jaip.2023.01.008_bib106","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-065X.2011.01032.x","article-title":"Human asthma phenotypes: from the clinic, to cytokines, and back again","volume":"242","author":"Bhakta","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2023.01.008_bib107","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/all.15229","article-title":"Climate change and global health: a call to more research and more action","volume":"77","author":"Agache","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.01.008_bib108","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jaci.2021.10.011","article-title":"Climate change and global issues in allergy and immunology","volume":"148","author":"Pacheco","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib109","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12016-011-8263-1","article-title":"The challenge of asthma in minority populations","volume":"43","author":"Leong","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib110","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMe2114944","article-title":"Need for racial and ethnic diversity in asthma precision medicine","volume":"385","author":"Gonz\u00e1lez Burchard","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib111","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJMe2201666","article-title":"Breaking the skin color barriers for asthma medications\u2014it's not Black, Brown, or White","volume":"386","author":"Bryant-Stephens","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib112","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02168-2021","article-title":"3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD","volume":"58","author":"Porsbjerg","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.01.008_bib113","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/ard.2011.149765","article-title":"American College of Rheumatology\/European League against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","volume":"70","author":"Felson","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2023.01.008_bib114","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2222.2008.03157.x","article-title":"Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype","volume":"39","author":"Dougherty","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.01.008_bib115","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1164\/rccm.202007-2721OC","article-title":"Expert consensus on the tapering of oral corticosteroids for the treatment of asthma. A Delphi study","volume":"203","author":"Suehs","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib116","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/JAA.S176026","article-title":"Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study","volume":"11","author":"Price","year":"2018","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2023.01.008_bib117","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fped.2019.00320","article-title":"Predicting asthma using clinical indexes","volume":"7","author":"Castro-Rodriguez","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2023.01.008_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106866","article-title":"Identifying asthma patients at high risk of exacerbation in a routine visit: a machine learning model","volume":"198","author":"Jiao","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2023.01.008_bib119","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2018.03.010","article-title":"Asthma across the lifespan: time for a paradigm shift","volume":"142","author":"Szefler","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.008_bib120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/thoraxjnl-2018-212441","article-title":"Measuring lung function in airways diseases: current and emerging techniques","volume":"74","author":"Petousi","year":"2019","journal-title":"Thorax"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823000697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823000697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:35:31Z","timestamp":1761975331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823000697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2213219823000697"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.01.008","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward a Predict and Prevent Approach in Obstructive Airway Diseases","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}